Glenmark Pharmaceuticals Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Dec '24
Sep '24
Jun '24
Mar '24
Dec '23
Total Qtr Revenue cr
3,418.68
3,473.21
3,275.68
3,836.12
2,552.11
Other Income Qtr Cr31.1339.4231.49773.1645.41
Operating Revenues Qtr3,387.553,433.803,244.193,062.952,506.70

*All values are in Cr.

Operating Expenses Qtr
2,787.32
2,831.88
2,655.97
2,558.61
2,715.35
Operating Profit Qtr
600.23
601.91
588.21
504.34
-208.65
EBIDT Qtr Cr
631.36
641.33
619.70
855.10
-121.20
Depreciation Qtr
122.74
120.28
117.79
151.34
147.08
Net Profit Qtr
347.96
354.21
340.27
-1,218.28
-351.38
Basic EPS Qtr
12.33
12.55
12.06
-43.18
-12.45
Open Demat Account
+91 -

personImage
Open Demat Account
+91 -